Plasma metabolomic biomarkers of mixed nuts exposure inversely correlate with severity of metabolic syndrome (Q35789943)

10 August 2017

Plasma metabolomic biomarkers of mixed nuts exposure inversely correlate with severity of metabolic syndrome (English)

1 reference

10 August 2017

0 references

1 reference

Mar Garcia-Aloy

3

0 references

Sara Tulipani

Sara Tulipani

2

0 references

Cristina Andres-Lacueva

Cristina Andres-Lacueva

6

0 references

Mònica Bulló

Mònica Bulló

4

0 references

Ximena Mora-Cubillos

1

Ximena Mora-Cubillos

1 reference

10 August 2017

Francisco J Tinahones

5

1 reference

10 August 2017

28 September 2015

1 reference

Molecular Nutrition and Food Research

10 August 2017

1 reference

10 August 2017

59

1 reference

10 August 2017

2480-2490

1 reference

10 August 2017

12

1 reference

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

10 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Dietary composition and nutrient content of the New Nordic Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Nuts in the prevention and treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Effect of tree nuts on metabolic syndrome criteria: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Nut consumption is associated with decreased health risk factors for cardiovascular disease and metabolic syndrome in U.S. adults: NHANES 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Nut consumption and incidence of metabolic syndrome after 6-year follow-up: the SUN (Seguimiento Universidad de Navarra, University of Navarra Follow-up) cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Cross-sectional assessment of nut consumption and obesity, metabolic syndrome and other cardiometabolic risk factors: the PREDIMED study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Long-term associations of nut consumption with body weight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Insights into the role of the microbiome in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

The food metabolome: a window over dietary exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

The use of metabolomics for the discovery of new biomarkers of effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Nutrimetabolomic strategies to develop new biomarkers of intake and health effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Metabolic phenotyping in clinical and surgical environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Metabolomics unveils urinary changes in subjects with metabolic syndrome following 12-week nut consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Comparative analysis of sample preparation methods to handle the complexity of the blood fluid metabolome: when less is more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

New and vintage solutions to enhance the plasma metabolome coverage by LC-ESI-MS untargeted metabolomics: the not-so-simple process of method performance evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

New biomarkers of coffee consumption identified by the non-targeted metabolomic profiling of cohort study subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Metabolomics study of human urinary metabolome modifications after intake of almond (Prunus dulcis (Mill.) D.A. Webb) skin polyphenols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

An R package to analyse LC/MS metabolomic data: MAIT (Metabolite Automatic Identification Toolkit).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Peak aggregation as an innovative strategy for improving the predictive power of LC-MS metabolomic profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

HMDB 3.0--The Human Metabolome Database in 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

MassTRIX reloaded: combined analysis and visualization of transcriptome and metabolome data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

MassBank: a public repository for sharing mass spectral data for life sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Proposed minimum reporting standards for chemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

pROC: an open-source package for R and S+ to analyze and compare ROC curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Consumption and portion sizes of tree nuts, peanuts and seeds in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Effects of ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Occurrence of dicarboxylic (dioic) acids in some Mediterranean nuts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

21 January 2018

Metabolic flexibility

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Time course production of urolithins from ellagic acid by human gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Urolithins Are the Main Urinary Microbial-Derived Phenolic Metabolites Discriminating a Moderate Consumption of Nuts in Free-Living Subjects with Diagnosed Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

Novel Multimetabolite Prediction of Walnut Consumption by a Urinary Biomarker Model in a Free-Living Population: the PREDIMED Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500549

21 January 2018

Identifiers

DOI

10.1002/MNFR.201500549

1 reference

10 August 2017

1 reference

PubMed ID

26412215